HEADER OXIDOREDUCTASE 08-SEP-17 6AYB TITLE NAEGLERIA FOWLERI CYP51-KETOCONAZOLE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYP51, STEROL 14ALPHA-DEMETHYLASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: CYS 371 AND CYS 392 ARE SPONTANEOUSLY OXIDIZED TO COMPND 6 SULFENIC ACID CSO SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NAEGLERIA FOWLERI; SOURCE 3 ORGANISM_TAXID: 5763; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_PLASMID: PCW-LIC KEYWDS CYP51, STEROL 14ALPHA-DEMETHYLASE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR A.DEBNATH,C.M.CALVET,G.JENNINGS,W.ZHOU,A.AKSENOV,M.LUTH,R.ABAGYAN, AUTHOR 2 W.D.NES,J.H.MCKERROW,L.M.PODUST REVDAT 5 23-OCT-24 6AYB 1 REMARK REVDAT 4 15-NOV-23 6AYB 1 REMARK REVDAT 3 04-OCT-23 6AYB 1 REMARK REVDAT 2 10-JAN-18 6AYB 1 JRNL REVDAT 1 22-NOV-17 6AYB 0 JRNL AUTH A.DEBNATH,C.M.CALVET,G.JENNINGS,W.ZHOU,A.AKSENOV,M.R.LUTH, JRNL AUTH 2 R.ABAGYAN,W.D.NES,J.H.MCKERROW,L.M.PODUST JRNL TITL CYP51 IS AN ESSENTIAL DRUG TARGET FOR THE TREATMENT OF JRNL TITL 2 PRIMARY AMOEBIC MENINGOENCEPHALITIS (PAM). JRNL REF PLOS NEGL TROP DIS V. 11 06104 2017 JRNL REFN ESSN 1935-2735 JRNL PMID 29284029 JRNL DOI 10.1371/JOURNAL.PNTD.0006104 REMARK 2 REMARK 2 RESOLUTION. 1.87 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 70.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 34450 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.245 REMARK 3 R VALUE (WORKING SET) : 0.243 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1836 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3527 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 100 REMARK 3 SOLVENT ATOMS : 85 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.85 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.23000 REMARK 3 B22 (A**2) : 0.89000 REMARK 3 B33 (A**2) : -1.78000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.22000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.205 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.180 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.191 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.777 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 6AYB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-SEP-17. REMARK 100 THE DEPOSITION ID IS D_1000229998. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-SEP-16 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.11587 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36286 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.870 REMARK 200 RESOLUTION RANGE LOW (A) : 70.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : 6.070 REMARK 200 R MERGE (I) : 0.20300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.7900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.87 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 68.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 1.88700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.530 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.2 REMARK 200 STARTING MODEL: 5TL8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 33% PEG MME 550, 0.03 CACL2, 4% REMARK 280 JEFFAMINE M-600, 0.1 M BIS-TRIS PROPANE, PH 6.9, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 59.60500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.62500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 59.60500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.62500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 26 REMARK 465 ALA A 27 REMARK 465 LYS A 28 REMARK 465 LYS A 29 REMARK 465 THR A 30 REMARK 465 SER A 31 REMARK 465 SER A 32 REMARK 465 LYS A 33 REMARK 465 GLY A 34 REMARK 465 GLN A 484 REMARK 465 GLN A 485 REMARK 465 HIS A 486 REMARK 465 HIS A 487 REMARK 465 HIS A 488 REMARK 465 HIS A 489 REMARK 465 HIS A 490 REMARK 465 HIS A 491 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 35 CG CD CE NZ REMARK 470 LEU A 36 CG CD1 CD2 REMARK 470 VAL A 51 CG1 CG2 REMARK 470 LYS A 88 CG CD CE NZ REMARK 470 LYS A 95 CG CD CE NZ REMARK 470 LYS A 160 CE NZ REMARK 470 GLN A 193 OE1 NE2 REMARK 470 LYS A 198 CD CE NZ REMARK 470 GLU A 235 CD OE1 OE2 REMARK 470 LYS A 243 CG CD CE NZ REMARK 470 LYS A 250 CG CD CE NZ REMARK 470 LEU A 256 CG CD1 CD2 REMARK 470 GLU A 258 CG CD OE1 OE2 REMARK 470 LYS A 260 CE NZ REMARK 470 GLN A 276 CG CD OE1 NE2 REMARK 470 LYS A 318 CE NZ REMARK 470 LYS A 321 CG CD CE NZ REMARK 470 GLU A 324 OE1 OE2 REMARK 470 LYS A 331 CG CD CE NZ REMARK 470 LYS A 367 CG CD CE NZ REMARK 470 ARG A 369 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 370 CG CD OE1 OE2 REMARK 470 GLU A 372 CD OE1 OE2 REMARK 470 THR A 393 OG1 CG2 REMARK 470 LYS A 415 CE NZ REMARK 470 ARG A 427 CZ NH1 NH2 REMARK 470 LYS A 458 CG CD CE NZ REMARK 470 LYS A 483 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 HIS A 266 O HOH A 601 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 46 -59.43 60.03 REMARK 500 ASN A 56 95.60 -178.53 REMARK 500 ASP A 70 -26.01 -30.68 REMARK 500 LEU A 77 62.42 36.76 REMARK 500 GLU A 100 -60.35 -91.17 REMARK 500 PHE A 109 -22.41 -39.56 REMARK 500 VAL A 119 -105.04 45.94 REMARK 500 LEU A 139 56.06 -109.47 REMARK 500 ALA A 223 75.52 -152.25 REMARK 500 GLU A 372 -128.71 43.64 REMARK 500 ASN A 398 57.18 29.43 REMARK 500 LYS A 415 -37.51 -35.72 REMARK 500 TYR A 464 35.13 -85.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE A 451 ASP A 452 149.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 501 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 430 SG REMARK 620 2 HEM A 501 NA 97.3 REMARK 620 3 HEM A 501 NB 83.7 89.4 REMARK 620 4 HEM A 501 NC 83.2 178.5 89.4 REMARK 620 5 HEM A 501 ND 96.6 90.8 179.6 90.4 REMARK 620 6 KKK A 508 N2 172.8 84.9 89.4 94.4 90.3 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CA A 507 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KKK A 508 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TL8 RELATED DB: PDB REMARK 900 5TL8 CONTAINS THE SAME PROTEIN COMPLEXED WITH POSACONAZOLE REMARK 900 RELATED ID: 6AY4 RELATED DB: PDB REMARK 900 6AY4 CONTAINS THE SAME PROTEIN COMPLEXED WITH FLUCONAZOLE REMARK 900 RELATED ID: 6AY6 RELATED DB: PDB REMARK 900 6AY6 CONTAINS THE SAME PROTEIN COMPLEXED WITH VORICONAZOLE DBREF 6AYB A 26 491 PDB 6AYB 6AYB 26 491 SEQRES 1 A 466 MET ALA LYS LYS THR SER SER LYS GLY LYS LEU PRO PRO SEQRES 2 A 466 ARG VAL PRO ASN LEU ILE PRO TYR VAL GLY SER PHE VAL SEQRES 3 A 466 SER PHE ALA LYS ASN PRO VAL GLN PHE ILE ILE ASP ASN SEQRES 4 A 466 SER LYS LYS TYR GLY ASP VAL PHE THR ALA THR ILE LEU SEQRES 5 A 466 GLY LYS GLU MET THR PHE LEU ASN HIS PRO LYS ILE LEU SEQRES 6 A 466 ASP THR PHE PHE LYS ALA THR ASP ASN GLU LEU SER LEU SEQRES 7 A 466 ARG ASP VAL TYR ARG PHE MET ARG PRO VAL PHE GLY THR SEQRES 8 A 466 GLY VAL VAL TYR ASP ALA ASP SER THR GLU ARG MET MET SEQRES 9 A 466 GLU GLN VAL LYS PHE VAL SER SER GLY LEU THR THR ALA SEQRES 10 A 466 ARG PHE ARG VAL PHE VAL ASP ILE PHE GLU ASP GLU ILE SEQRES 11 A 466 ALA HIS LYS VAL LYS GLU LEU GLY PRO GLU GLY THR VAL SEQRES 12 A 466 ASP VAL ALA GLU LEU MET ALA ASP LEU ILE ILE PHE THR SEQRES 13 A 466 ALA SER ARG CYS LEU LEU GLY ASP GLU VAL ARG GLN TYR SEQRES 14 A 466 LEU SER GLU LYS ASN LEU GLY LYS LEU TYR HIS ASP ILE SEQRES 15 A 466 ASP ASP GLY ILE SER PRO LEU SER PHE PHE TYR PRO SER SEQRES 16 A 466 LEU PRO ALA PRO LYS ARG ASP LYS ALA ARG LYS ALA VAL SEQRES 17 A 466 GLY GLU ILE PHE GLN GLU LEU LEU ASP LYS ARG ARG GLU SEQRES 18 A 466 GLU HIS LYS LYS HIS PRO GLU ARG LEU LEU ASP GLU SER SEQRES 19 A 466 LYS MET ASP VAL VAL ASP HIS LEU LEU THR GLN LYS TYR SEQRES 20 A 466 LYS ASP GLY GLN GLU LEU THR ASP VAL HIS ARG ILE GLY SEQRES 21 A 466 ILE LEU ILE ALA GLY LEU PHE ALA GLY GLN HIS THR SER SEQRES 22 A 466 SER ILE THR SER SER TRP THR LEU MET ASN VAL ILE SER SEQRES 23 A 466 ASN LYS LYS VAL LEU GLU LYS VAL ARG LYS GLU GLN GLU SEQRES 24 A 466 GLU ILE MET GLY SER ASP LYS VAL LEU ASP TYR ASP LYS SEQRES 25 A 466 VAL MET LYS MET ASP TYR LEU GLU ALA CYS MET LYS GLU SEQRES 26 A 466 ALA LEU ARG MET TYR PRO PRO LEU ILE MET ILE MET ARG SEQRES 27 A 466 MET ALA ARG LYS PRO ARG GLU CSO GLU GLN TYR ILE ILE SEQRES 28 A 466 PRO LYS GLY ASN ILE LEU VAL VAL SER PRO SER VAL ALA SEQRES 29 A 466 GLY ARG CSO THR ASP THR TYR THR ASN PRO ASP VAL PHE SEQRES 30 A 466 ASP PRO GLU ARG LEU THR GLU ARG LYS GLU HIS GLU LYS SEQRES 31 A 466 PHE LYS TYR GLY ALA VAL PRO PHE GLY ALA GLY ARG HIS SEQRES 32 A 466 LYS CYS ILE GLY GLU ASN PHE ALA LEU LEU GLN VAL LYS SEQRES 33 A 466 SER ILE ILE SER ILE LEU LEU ARG TYR PHE ASP MET GLU SEQRES 34 A 466 TYR ILE GLY LYS ILE PRO ASP PRO SER TYR THR SER LEU SEQRES 35 A 466 VAL VAL GLY PRO SER PRO PRO THR ARG MET ARG TYR LYS SEQRES 36 A 466 LEU ARG LYS GLN GLN HIS HIS HIS HIS HIS HIS HET CSO A 371 7 HET CSO A 392 7 HET HEM A 501 43 HET EDO A 502 4 HET EDO A 503 4 HET EDO A 504 4 HET EDO A 505 4 HET EDO A 506 4 HET CA A 507 1 HET KKK A 508 36 HETNAM CSO S-HYDROXYCYSTEINE HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM EDO 1,2-ETHANEDIOL HETNAM CA CALCIUM ION HETNAM KKK 1-ACETYL-4-(4-{[(2R,4S)-2-(2,4-DICHLOROPHENYL)-2-(1H- HETNAM 2 KKK IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4- HETNAM 3 KKK YL]METHOXY}PHENYL)PIPERAZINE HETSYN HEM HEME HETSYN EDO ETHYLENE GLYCOL FORMUL 1 CSO 2(C3 H7 N O3 S) FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 EDO 5(C2 H6 O2) FORMUL 8 CA CA 2+ FORMUL 9 KKK C26 H28 CL2 N4 O4 FORMUL 10 HOH *85(H2 O) HELIX 1 AA1 SER A 49 ASN A 56 1 8 HELIX 2 AA2 ASN A 56 GLY A 69 1 14 HELIX 3 AA3 HIS A 86 ILE A 89 5 4 HELIX 4 AA4 LEU A 90 ALA A 96 1 7 HELIX 5 AA5 LEU A 103 ARG A 108 1 6 HELIX 6 AA6 MET A 110 GLY A 115 1 6 HELIX 7 AA7 VAL A 118 ALA A 122 5 5 HELIX 8 AA8 SER A 124 SER A 137 1 14 HELIX 9 AA9 THR A 140 GLY A 163 1 24 HELIX 10 AB1 VAL A 170 GLY A 188 1 19 HELIX 11 AB2 VAL A 191 LYS A 198 1 8 HELIX 12 AB3 ASN A 199 GLY A 210 1 12 HELIX 13 AB4 ILE A 211 PHE A 217 5 7 HELIX 14 AB5 ALA A 223 HIS A 251 1 29 HELIX 15 AB6 GLU A 253 ASP A 257 5 5 HELIX 16 AB7 ASP A 262 GLN A 270 1 9 HELIX 17 AB8 THR A 279 SER A 311 1 33 HELIX 18 AB9 ASN A 312 GLY A 328 1 17 HELIX 19 AC1 ASP A 334 LYS A 340 1 7 HELIX 20 AC2 MET A 341 TYR A 355 1 15 HELIX 21 AC3 SER A 385 CSO A 392 1 8 HELIX 22 AC4 PRO A 404 GLU A 409 1 6 HELIX 23 AC5 LYS A 411 PHE A 416 5 6 HELIX 24 AC6 ALA A 425 LYS A 429 5 5 HELIX 25 AC7 GLY A 432 TYR A 450 1 19 SHEET 1 AA1 5 VAL A 71 ILE A 76 0 SHEET 2 AA1 5 LYS A 79 LEU A 84 -1 O MET A 81 N ALA A 74 SHEET 3 AA1 5 ILE A 381 VAL A 384 1 O VAL A 383 N LEU A 84 SHEET 4 AA1 5 ILE A 361 ALA A 365 -1 N ILE A 361 O VAL A 384 SHEET 5 AA1 5 LEU A 101 SER A 102 -1 N SER A 102 O MET A 364 SHEET 1 AA2 3 GLU A 165 ASP A 169 0 SHEET 2 AA2 3 ARG A 476 LEU A 481 -1 O MET A 477 N VAL A 168 SHEET 3 AA2 3 PHE A 451 TYR A 455 -1 N ASP A 452 O LYS A 480 SHEET 1 AA3 2 ARG A 369 CSO A 371 0 SHEET 2 AA3 2 TYR A 374 ILE A 376 -1 O ILE A 376 N ARG A 369 SHEET 1 AA4 2 PRO A 462 SER A 463 0 SHEET 2 AA4 2 GLY A 470 PRO A 471 -1 O GLY A 470 N SER A 463 LINK C GLU A 370 N CSO A 371 1555 1555 1.34 LINK C CSO A 371 N GLU A 372 1555 1555 1.33 LINK C ARG A 391 N CSO A 392 1555 1555 1.33 LINK C CSO A 392 N THR A 393 1555 1555 1.34 LINK O LEU A 84 CA CA A 507 1555 1555 2.88 LINK SG CYS A 430 FE HEM A 501 1555 1555 2.36 LINK FE HEM A 501 N2 KKK A 508 1555 1555 2.24 CISPEP 1 PRO A 473 PRO A 474 0 5.20 SITE 1 AC1 19 TYR A 107 TYR A 120 ALA A 293 THR A 297 SITE 2 AC1 19 THR A 301 PRO A 357 LEU A 358 ILE A 361 SITE 3 AC1 19 ARG A 363 PRO A 422 PHE A 423 GLY A 424 SITE 4 AC1 19 HIS A 428 CYS A 430 ILE A 431 GLY A 432 SITE 5 AC1 19 PHE A 435 KKK A 508 HOH A 632 SITE 1 AC2 1 VAL A 332 SITE 1 AC3 5 ASP A 208 ILE A 211 SER A 466 LEU A 467 SITE 2 AC3 5 VAL A 468 SITE 1 AC4 4 LYS A 349 HIS A 413 ALA A 420 HOH A 614 SITE 1 AC5 5 ARG A 320 GLN A 323 GLU A 324 ARG A 449 SITE 2 AC5 5 ARG A 482 SITE 1 AC6 4 TYR A 204 ILE A 207 ASP A 208 GLN A 295 SITE 1 AC7 3 LEU A 84 ASN A 85 SER A 385 SITE 1 AC8 12 TYR A 107 PHE A 114 TYR A 120 PRO A 213 SITE 2 AC8 12 PHE A 217 PHE A 292 ALA A 293 THR A 297 SITE 3 AC8 12 LEU A 358 MET A 360 LEU A 467 HEM A 501 CRYST1 119.210 55.250 71.620 90.00 100.13 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008389 0.000000 0.001499 0.00000 SCALE2 0.000000 0.018100 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014184 0.00000